DUSA Share Price

Open 21.60 Change Price %
High 21.60 1 Day -0.17 -0.78
Low 21.44 1 Week -0.16 -0.74
Close 21.49 1 Month 0.45 2.14
Volume 14122 1 Year 13.49 168.62
52 Week High 21.78
52 Week Low 19.79
DUSA Important Levels
Resistance 2 21.64
Resistance 1 21.58
Pivot 21.51
Support 1 21.40
Support 2 21.34
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
QQQ 143.96 -0.63%
SIRI 5.83 8.16%
FB 170.44 2.92%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SHOR 7.50 28.21%
OPNT 14.53 27.46%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
LPSN 13.50 18.42%
TREE 217.15 18.14%
AXTI 8.80 15.79%
DRYS 1.20 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
IPCI 1.36 -45.38%
DVOX 0.05 -44.44%
GLCH 0.70 -44.00%
PRXI 0.21 -43.24%
More..

DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA)

DUSA Technical Analysis 5
As on 27th Jul 2017 DUSA Share Price closed @ 21.49 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 14.59 & Strong Buy for SHORT-TERM with Stoploss of 20.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
DUSA Target for July
1st Target up-side 21.29
2nd Target up-side 21.46
3rd Target up-side 21.63
1st Target down-side 20.79
2nd Target down-side 20.62
3rd Target down-side 20.45
DUSA Other Details
Segment EQ
Market Capital 155506272.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
DUSA Address
DUSA
N/A
DUSA Latest News
Interactive Technical Analysis Chart DUSA Pharmaceuticals, Inc. ( DUSA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on DUSA Pharmaceuticals, Inc.
DUSA Business Profile
DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company�s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp. During the year ended December 31, 2011, it initiated an exploratory DUSA-sponsored clinical trial designed to study the broad area application and/or short drug incubation (BASDI), method of using the Levulan Kerastick, which is being carried out at 10 clinical trial sites. DUSA manufactures its Levulan Kerastick in its Wilmington, Massachusetts facility. Its wholly owned subsidiaries include DUSA Pharmaceuticals New York, Inc. and Sirius Laboratories, Inc. As of December 31, 2011, DUSA ceased marketing and selling its remaining Non-PDT products, which were ClindaReach and Meted.